Pharmaceutical

Sanofi and Orano Med link for radioligand therapy development

Sanofi and Orano Group subsidiary Orano Med have announced a partnership to enhance the development of next-generation RLTs.

Oct 20, 2024 - 04:00
Sanofi and Orano Med link for radioligand therapy development
Sanofi and Orano Group subsidiary Orano Med have announced a partnership to enhance the development of next-generation RLTs.
Read the original article

Tags:

Previous Article

Unresolved clawback issues obstruct Greece’s potential pharmaceutical framework ...

Next Article

Opioid addiction market to reach $2.4 billion across 8MM by 2033

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Tyra gains orphan drug status from FDA for achondroplasia therapy

Tyra gains orphan drug status from FDA for achondroplas...

Aug 2, 2023

STAT+: What FDA mandate? Sun Pharma halts shipments from a plant with a troubled history

STAT+: What FDA mandate? Sun Pharma halts shipments fro...

May 9, 2023

STAT+: Pharmalittle: Vertex and U.K. at odds over value of CF meds; French authorities probe Sanofi over alleged market manipulation

STAT+: Pharmalittle: Vertex and U.K. at odds over value...

Nov 7, 2023